Efficacy and Safety of Teplizumab in Japanese Participants With Stage 2 Type 1 Diabetes

NCT06791291 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG: Teplizumab

Sponsor

Sanofi